Cancel

Emerging Immunotherapies in Bladder Cancer: PD-1, PD-LI, and CTLA-4 Inhibitors

Goal: The goal of this educational activity is to improve clinicians’ abilities to diagnose and treat bladder cancer appropriately, with particular emphasis on emerging therapies such as PD-1, PD-L1, and CTLA-4 inhibitors. Learning Objectives: At the completion of this activity, participants should be better able to: 1. Discuss the pathophysiology of bladder cancer, including the role of the PD-1, PD-L1, and CTLA-4 pathways. 2. Explain the diagnosis and staging of bladder cancer...
Applied Clinical Education

New Oral Anticoagulants: Factor IIa and Xa Inhibitors

In this knowledge-based continuing pharmacy education activity Dr Michael Smith, RPh, PharmD, CACP discusses the new oral anticoagulation agents. Target Audience: Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy This activity is not accredited for technicians Learning objectives: At the conclusion of the activity, pharmacists will be able to: 1. ...
University of Connecticut School of Pharmacy

2015 - Neonatal Pharmacology

2015 - Neonatal Pharmacology Content Origination Date: May 14, 2015 ‐ Content Expiration Date: May 27, 2018 Total CE Credits: This online conference offers cutting edge information from some of the leading clinicians and researchers in neonatology. You will learn from these experts how to integrate best practices into your unit for a broad range of neonatal drugs, as well as managing care in the light of drug shortages. A faculty of experts in neonatal pharmacology who will challenge ...
Contemporary Forums

Neonatal Skin: Bacterial Colonization, Disinfection and Antimicrobial Bathing

Learning Objectives: Introduce the concept of the skin microbiome, and what is known about adults, children and neonatal skin microbiome. Discuss use of skin disinfectants in the NICU in terms of efficacy, toxicity and skin irritation. Review studies related to bathing the newborn with antimicrobial solutions and identify the pros and cons of this practice.
Contemporary Forums

Neonatal Abstinence Syndrome: Something Borrowed, Something New: Are There Best Therapies?

Learning Objectives: Demonstrate improved understanding of current limitations of pharmacologic management of neonatal abstinence syndrome. Have an improved knowledge base of current management options for treating neonatal abstinence. Articulate the ethical and moral challenges and dilemmas in caring for mothers and infants exposed to illicit substances.
Contemporary Forums

Vitamin A in the NICU: An Expensive Therapy for BPD Reduction. Is It Worth It?

Learning Objectives: Describe the mechanism used by Vitamin A to reduce the severity of BPD. Describe the clinical evidence supporting the use of vitamin to reduce BPD. Determine if the use of Vitamin A is cost effective and worthwhile in their NICU population.
Contemporary Forums

Neonatal Drug Formulations: Safety Gains and Risks

Learning Objectives: Describe the legal and regulatory challenges to pharmaceutical compounding for neonates. Describe clinical risks associated with pharmaceutical compounding for neonates. List compounded neonatal medications with recently published formulations.
Contemporary Forums

What's New in Neonatal Pharmacology and Drug Dosing?

Learning Objectives: Describe new dosing guidelines for at least 1 medication. Describe new safety information for at least 1 medication. Describe FDA final rule regarding drug labeling for use in pregnancy and lactation.
Contemporary Forums

Optimal Nutritional Management After Discharge in the Term and Preterm Neonate

Learning Objectives: List the limitations of our current nutritional discharge process. Identify the areas in nutrition that are important to consider for the growing preterm infant. Develop a framework that clearly creates a detailed nutritional discharge plan for your NICU.
Contemporary Forums

A Skeptic's View of Neonatal Medicine: Balancing Science and Art

Learning Objectives: Describe the indications for the use of bicarbonate in the NICU. Discuss the risks and benefits of postnatal steroids for BPD. Describe the limitations of probiotics for the prevention of NEC.
Contemporary Forums

Delivery Room Emergencies: Case Studies

Learning Objectives: Apply clinical assessment skills to the care of complex neonatal cases in delivery room. Discuss etiology, pathophysiology and management of selected neonatal cases. Describe emerging technologies and new therapies for these cases.
Contemporary Forums

Don't Forget the Kidneys! Renal Failure in the NICU Patient

Learning Objectives: Review key alterations in renal function compared to the adult. Develop an initial management plan for the infant with acute renal failure. Discuss potential long-term complications related to acute renal failure.
Contemporary Forums

Challenging Cases in Neonatal Ethics

Learning Objective: List the four basic principles of pediatric ethics. Discuss how pediatric ethics principles apply to newborns. Identify the challenges that arise when caregivers and parents disagree on the provision of care for critically ill newborns.
Contemporary Forums

Simulation in the Real World

Learning Objectives: List 5 major applications of healthcare simulation. Describe examples of improvements in outcomes from healthcare simulation. Review future directions & challenges in healthcare simulation
Contemporary Forums

Advances in Neonatal Medicine 2015

Learning Objectives: To know the limits of viability according to outcome data in 2015. To recognize the value of quality improvement in reducing mortality and morbidity. To be aware of the benefits of early nutrition and feeding human milk to preterm infants.
Contemporary Forums

Pharmacologic and Non-Pharmacologic Management of Neonatal Abstinence Syndrome

Learning Objectives: Describe the opioid epidemic in the United States Review the mechanisms of action of opiates and what causes withdrawal symptoms Describe current treatment strategies for NAS and outcomes
Contemporary Forums

Recognition and Management of Arrhythmias in the Fetus and Newborn

Learning Objectives: Recognize common fetal arrhythmias. Recognize common newborn arrhythmias. Recognize appropriate and inappropriate use of newborn EKGs.
Contemporary Forums

What's New for Antibiotics in the NICU?

Learning Objectives:​ Describe the goals of antimicrobial therapy. Describe how dosing is modified to achieve the goals of antimicrobial therapy. Describe dosing guidelines of medication used to treat infants with serious infections.
Contemporary Forums

The Synagis Debate: RSV Risk, Revised Recommendations, and Rising Cost

Learning Objectives: Discuss the prevalence of RSV and risk of hospitalization from severe disease across all neonatal and infant populations. Analyze data regarding palivizumab efficacy and cost effectiveness. Review revised 2014 palivizumab recommendations and discuss validity of changes.
Contemporary Forums

Current Neonatal Pain and Sedation Strategies: From Morphine to Dexmedetomidine

Learning Objectives: Discuss the effects of neonatal pain on brain development. Describe potential short- and long-term risks and benefits of morphine and dexmedetomidine in neonates. Providers will have increased knowledge on pain and sedation strategies in critically ill neonates.
Contemporary Forums

What is the Role for Steroids in Newborns with Cardiovascular Insufficiency?

Learning Objectives: Describe the basics of cortisol synthesis and physiology. Define relative adrenal insufficiency. Describe options for treatment of cardiovascular insufficiency.
Contemporary Forums

Acute and Chronic Leukemias 2017

This is a two-day comprehensive symposium that will feature interactive case presentations with a panel of experts weighing in on pivotal treatment issues as well as taking questions from the audience. These sessions will highlight standard of care, new treatments, side effects of treatment, as well as any pertinent clinical issues of a specific diagnosis. The interactive case presentations topics will be: Chronic Myeloid Leukemia, Myeloproliferative Neoplasms, Acute Myeloid Leukemia, and C...
Mayo Clinic

Live CE/CME Bahamas Cruise - Addressing Complications Commonly Seen in Medically Ill Patients.

Treating everyday illness in the presences of opioid misuse and addiction, Opioids and benzodiazepines; a review of the recent FDA black box warnings and CDC guidelines updates, Managing chronic non-cancer pain (5 hrs) Antipsychotic update, Therapeutic review and clinical pearls, Using antipsychotics in patients with dementia (5 hrs) Movement Disorders, Drug induced movement disorders, Parkinson’s Disease Novel Agents used in patients with concurrent psychosis (5 hrs)
University Learning Systems

Live CE/CME in Kauai - Cardiovascular, Pulmonary and Antimicrobial Primary Care Update

Antimicrobial Agents for Use in Primary Care, Clinically Relevant Drug Interactions Encountered in Primary Care, Avoiding Polypharmacy in the Elderly Pharmacotherapeutic Options for Managing Asthma and Chronic Obstructive Pulmonary Disease (COPD) Case Based Application of New Guidelines for Hypertension and Heart Failure
University Learning Systems

Live CE/CME in Las Vegas - Current Topics in HealthCare: 2017

Session One Topic to be Determined Session Two Pharmacotherapy Update on Arthritis: Medications, Updates Recommendations and the Impact of Biosimilar Agents Session Three The New Definition of Abuse: Diversion (The Illicit Use of Prescription Drugs)
University Learning Systems

Expert Answers to Frequently Asked Questions About Biosimilars

Topics covered include: Biosimilars vs Small Molecular Generics Biosimilars vs Reference Biologics Regulatory Pathway for Biosimilars Interchangeability of Biosimilars Biosimilars Approved in the US
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Diagnostic and Therapeutic Strategies for the Management of Acquired Hemophilia A

FREE CME/CNE Activity. The rarity of acquired hemophilia A (AHA) has resulted in a lack of awareness among clinicians, and this potentially life-threatening bleeding diathesis may go unrecognized. Although the two-fold objectives of treating AHA are clear—to control bleeding and remove the inhibitor—management is complex and often challenging. Diagnosis may be delayed, and AHA may be mistaken for congenital or other acquired bleeding disorders. The etiology of AHA is frequently unexplained...
Postgraduate Institute for Medicine

Hemophilia Perspectives: An Update on Risk Stratification, Eradication, and Management of Hemophilia Patients with Inhibitors

Inhibitor development represents the most severe adverse event of replacement therapy in hemophilia A patients in high-income countries. The management of hemophilia patients with inhibitors remains a challenge in spite of great strides in the understanding of risk factors involved in inhibitor development. Conflicting data need to be addressed by further studies, in particular with respect to factors potentially modifiable by clinical choices, including regimens of treatment and the highly de...
Postgraduate Institute for Medicine

OROFACIAL PAIN: WHEN, HOW AND WHAT TO TREAT

This course focuses on Chronic Orofacial Pain (OFP) and headaches (e.g. Neuropathic Pain, Neurovascular Pain, Neuralgia, Neuritis and Neuroma). It reviews underlying mechanisms of pain induction, nerve injury and repair, sensitization and spontaneous ectopic pain generation. Lectures include an explanation of how various analgesic blocks and sensory testing procedures, in combination with historical information, produce a differential diagnosis of neurogenous and headache pain. Lectures will a...
Herman Ostrow School of Dentistry of USC

Marijuana Use in Healthcare

In this 45 min course on medical marijuana you will learn the basics of medical marijuana and be able to engage in conversation with your patients. Learning Objectives: Identify the major cannabinoids present in marijuana Discuss barriers to marijuana research Recognize potential indications for use of medical marijuana Identify future areas for study and potential clinical implications for marijuana and marijuana derived compounds Understand concerns of marijuana use
AltusCampus

FREE Patient Safety CME

Upgrade your practice of Patient Safety and earn FREE Patient Safety CME credits with Free Patient Safety CME programs from CMEList.com. Most programs are 1-2 hours long and feature slide-video lectures from specialists in Patient Safety.
CMEList.com

Designer Drugs: Bath Salts, Synthetic Cannabinoids, and Synthetic Hallucinogens

Designer drugs are synthetic compounds whose molecular structures have been modified based on chemically similar illicit drugs. The newly created substances can often be purchased legally because their modified chemical structures are not covered under existing drug laws. Since, in many cases, designer drugs are not yet illegal, they are inaccurately referred to as “legal highs” or “herbal highs.” This course gives an overview of the types of designer drugs and describes the challenges...
ATrain Education Inc.

Acute Lymphoblastic Leukemia (ALL): ASH 2014 Overview

In this online CME self-learning program: Acute lymphoblastic leukemia (ALL) is one of a group of malignancies caused by cytogenetic DNA mutations of developing hematopoietic stem cell precursors and mostly common to children with peak incidence at 2-5 years of age. Although approximately 80% of ALL cases present in children, they also occur in adults. The symptoms of ALL are non-specific and similar to those of acute myelogenous leukemia (ALL), which patients usually have 1-3 months ...
ScientiaCME

Adult Acute Lymphoblastic Leukemia (ALL) in Adults: 2015 Overview

In this online CME self-learning program: Acute lymphoblastic leukemia (ALL) is one of a group of malignancies caused by cytogenetic DNA mutations of developing hematopoietic stem cell precursors and mostly common to children with peak incidence at 2-5 years of age. Although approximately 80% of ALL cases present in children, they also occur in adults. The symptoms of ALL are non-specific and similar to those of acute myelogenous leukemia (ALL), which patients usually have 1-3 months ...
ScientiaCME

Acute Lymphoblastic Leukemia (ALL): Highlights from the 2015 American Society of Clinical Oncology (ASCO)

In this online CME self-learning program: Acute lymphoblastic leukemia (ALL) is one of a group of malignancies caused by cytogenetic DNA mutations of developing hematopoietic stem cell precursors and mostly common to children with peak incidence at 2-5 years of age. Although approximately 80% of ALL cases present in children, they also occur in adults. The symptoms of ALL are non-specific and similar to those of acute myelogenous leukemia (ALL), which patients usually have 1-3 months ...
ScientiaCME

Renal cell carcinoma (RCC): Highlights from the 2015 American Society of Clinical Oncology: Take-Aways, Emerging Practice Changes, and Barriers to their Implementation

In this online CME self-learning program: Renal cell carcinoma (RCC) is a cancer that is borne and takes root in the nephrons and is responsible for the vast majority – 85% – of all renal cancers. With risk factors that include smoking, obesity, cadmium exposure, older age, and genetics, the five year survival rate of those afflicted with kidney cancer overall is 68%. In part because there are not any clear early symptoms associated with kidney cancer, RCC is discovered predominan...
ScientiaCME

ONLINE CME: Contemporary Management of Hypertension And Cholesterol: Implications for Cardiovascular Prevention and System Approaches to Improve Patient Care

At the conclusion of this presentation, the participant should be able to: Review new clinical guidelines recommendations for the treatment of hypertension and dyslipidemia. List patient specific blood pressure goals for patients with hypertension. Identify appropriate and patient specific antihypertensive agents for the treatment of hypertension based on age, gender, and comorbid diseases. Recommend appropriate combination drug therapy for the treatment of hypertension. Identify 4 p...
University Learning Systems

ONLINE CME: Oral Chemotherapeutic Agents – Not Just Any Ordinary Pill

At the conclusion of this presentation, the participant should be able to: Identify the major classes of oral chemotherapeutic agents available on the market and recognize implications of the rapid rate of projected growth. Recognize the special considerations and key medication safety issues facing patients prescribed oral chemotherapy, their families, and healthcare professionals caring for them. Summarize the role and pharmacology of oral chemotherapy agents used in some of the most c...
University Learning Systems

ONLINE CME: Emerging and Re-Emerging Infectious Diseases

At the conclusion of this presentation, the participant should be able to: Define emerging and re-emerging infectious diseases and list numerous examples of emerging and re-emerging infectious diseases as defined by the Centers for Disease Control and Prevention. Discuss the factors contributing to the emergence and re-emergence of infectious diseases and explain the role of each factor in emergence and re-emergence. Review the prevalence of vaccine-preventable diseases (e.g., measles,...
University Learning Systems

Online CME: Heart Failure, Stable Ischemic Heart Disease, and Peripheral Arterial Disease

At the conclusion of this session, the participant should be able to: 1. Define the different types heart failure and recommended treatment approaches. 2. Describe recommendations from the American College of Cardiology/American Heart Association guidelines for patients with heart failure. 3. Review lifestyle recommendations that are needed in patients with heart failure. 4. Identify evidence related to the use of pharmacotherapy in the treatment of heart failure with reduced eject...
University Learning Systems

Online CME: Updates in Atrial Fibrillation, Secondary Prevention of Stroke, and Special Populations

At the conclusion of this session, the participant should be able to: 1. Describe recommendations from the American College of Cardiology/American Heart Association guidelines for patients with atrial fibrillation. 2. Explain the risks and benefits of rate and/or rhythm control in patients with atrial fibrillation. 3. Describe evidence supporting pharmacotherapy approaches for the treatment of chronic atrial fibrillation. 4. Determine how to use risk scoring tools to guide selection...
University Learning Systems

ONLINE CME: Bio This, Bio That; Understating Biologic Medications in the Treatment of Disease-Part 2 Online CE/CME Course

At the completion of this program, the participant should be able to: 1. Explain the role of biologic drug therapy in the treatment of infectious disease. 2. Explain the role of biologic drug therapy in the management of diabetes. 3. Explain the role of biologic drug therapy in the management of selected other disease states. 4. Discuss the risks and benefits associated with biologic drug therapy in each of these disease states. 5. Determine appropriate monitoring and management of the...
University Learning Systems

Anesthesia Pharmacology - 6 CEs available now

This Continuing Education Program is a series of 3 Audio Power-point lectures with corresponding test. This program allows THREE testing attempts. 1. Local Anesthetics 2. Induction Drugs 3. Perioperative Hypertension This Continuing Education Program is a series of 3 Audio Power-point lectures with corresponding test. This program allows THREE testing attempts. 1. Anaphylaxis Challenge Review 2. Anticoagulants Update; Newer Ones 3. Precedex Review
CRNA Today

Bioterrorism and Weapons of Mass Destruction

Defines terrorism, bioterrorism, and weapons of mass destruction and summarizes the diseases and agents most commonly used as chemical, biologic, radiologic, and nuclear weapons. Outlines CDC recommendations and best practices. When you finish this course, you will be able to: *Define terrorism, bioterrorism, and weapons of mass destruction (WMD) and list four main types of WMD. *For a chemical weapons event, summarize the agents most commonly used, the epidemiologic clues to and sympto...
ATrain Education Inc.

Pharmacy Spanish

This is a self-paced activity consists of 6 web-based instructional modules with active learning exercises, self-assessments and a written manual. It has been customized to teach you the Spanish you need for your profession. You will learn vital pronunciation skills since you will be speaking the language much more frequently than you will be writing it. Then you will learn grammatical formulas that will enable you to put together any necessary phrase or sentence for a variety of situations. Y...
University of Georgia College of Pharmacy

Audio-Digest Series Special - Clinical Pharmacology CME

Audio-Digest Series Special - Clinical Pharmacology CME represents a collection of Clinical Pharmacology lectures as they apply to various specialties. Some recent titles include: • Pharmacologic Therapy for Depression and Anxiety  • Treatment of Psychosis, Part 2: Antipsychotic Medications  • Pharmacotherapy: Where Do We Stand? • Bad for the Bones: Prescription Medications and Skeletal Deterioration  • Highlights from the 16th Annual Psychopharmacology Update  • Toxico...
Audio Digest

Audio-Digest Series Special Pain Management CME Package

The Audio-Digest Series Special Pain Management CME Package contains 35 programs related to pain management. Titles include: Rheumatic Diseases: An Update on Management; Perspectives on Pain Management; Interstitial Cystitis; Pointers in Pain Management; Common Pain Disorders in Primary Care; Low Back and Hip Pain; Headache: Trends in Treatment; Pain Management: A Primary Care Perspective; The Psychiatrist/Psychologist as Pain Manager; Pediatric Orthopedics; Pearls in Pain Management; Perioper...
AudioDigest

West Virginia: Drug Diversion Training, 1 unit

This course meets the 1-unit requirement for coursework in drug diversion mandated by West Virginia Senate Bill 437. It is for any licensee who participates in prescribing, dispensing, or administering controlled substances. Evidence-based information about the problem of drug diversion and the safeguards to prevent diversion, misuse, abuse, addiction, and overdose deaths. When you finish this course you will be able to: *Describe the five Schedules of medications under the Controlled...
ATrain Education Inc.

ONLINE CME: Bio This, Bio That; Understating Biologic Medications in the Treatment of Disease-Part 1 Online CE/CME Course

At the completion of this program, the participant should be able to: 1. Define what is a biologic medication. 2. Recognize the types of biological products. 3. Distinguish the differences between non-biologic and biologic medications. 4. Recognize the naming system for selected biologic medications. 5. Identify where biologic medications are currently used in the treatment of disease. 6. Review the basic pathophysiology of selected disease states that include biologic medications as p...
University Learning Systems

DVD COURSE: Type 2 Diabetes: An Evidence Based Pharmacotherapy Update

At the completion of this program, the participant should be able to: 1. Describe the relationship between obesity and the risk of Type 2 diabetes and the benefits of lifestyle modification (IE diet and exercise) in reducing the risk and helping to manage patients with Type 2 diabetes. 2. Describe the current ADA clinical practice guidelines for the diagnosis and management of diabetes mellitus. 3. Discuss the appropriate use of insulin, exanitide and oral agents in the management ...
University Learning Systems

YouTube Google+ Pinterest Twitter LinkedIn Facebook SlideShare
RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.